Written answers
Tuesday, 27 June 2017
Department of Health
Medicinal Products Reimbursement
John Curran (Dublin Mid West, Fianna Fail)
Link to this: Individually | In context | Oireachtas source
396. To ask the Minister for Health the position regarding the review being undertaken by his Department and the HSE following the decision of the NCPE in December 2016 to recommend against funding Respreeza; if the HSE or NCPE has met with a company (details supplied); if they reviewed the evidence presented in a second study published in a publication (details supplied); and if he will make a statement on the matter. [29930/17]
Simon Harris (Wicklow, Fine Gael)
Link to this: Individually | In context | Oireachtas source
The HSE has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drug schemes, in accordance with the provisions of the Health (Pricing and Supply of Medical Goods) Act 2013; therefore, the matter has been referred to the HSE for reply to the Deputy.
No comments